Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 21 to 30 of 158 resources

  • Guidelines on hepatitis B and C testing
    These are the first WHO guidelines on testing for chronic hepatitis B and C infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for hepatitis B and C, and are intended for use across age groups and populations.
    Rest of World Feb 2017 Other, Strategy & Planning PDF
  • HCV Action and PHE hepatitis C roadshow in Manchester: Presentations
    On 13th December 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Manchester. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Manchester and the wider north west region.
    UK, England, North West Other, Strategy & Planning PDF
  • Hepatitis C Commissioning Toolkit
    The Hepatitis C Commissioning Toolkit, an update to the original toolkit published in September 2013, sets out key commissioning responsibilities, with the intention of bringing clarity to an often highly fragmented commissioning landscape. The toolkit is also intended to aide commissioners in commissioning cost-effective services which are tailored to the needs of people with hepatitis C, by setting out how to ensure a clear, connected and properly funded hepatitis C care pathway, as well as providing good practice examples.
    England Case study, Tools & Templates, Strategy & Planning PDF
  • Drug-related infectious diseases in Europe
    This report provides an update on infectious diseases related to drug use in Europe for the period up to June 2016. It covers the most recent data both on infectious diseases among people who inject drugs in Europe, collected with the European Monitoring Centre for Drugs and Drug Addiction Drug-related infectious diseases (DRID) indicator, and on the responses in the area. It includes highlights and new findings discussed during the DRID indicator’s annual expert meeting, held in Lisbon on 6–8 June 2016.
    Rest of World Reports & Research PDF
  • The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
    This research paper, published in the International Journal of Drug Policy, examines how interferon-free treatments for hepatitis C are being understood and experienced by patients.
    UK Reports & Research PDF
  • Good practice case study: ROADS @ Bristol Drugs Project
    This HCV Action good practice case study looks at the work done by ROADS (Recovery Orientated Alcohol & Drugs Service) @ Bristol Drugs Project. When ROADS took over the service in November 2013, under 12% of clients assessed as appropriate to be tested for hepatitis C went on to actually be tested. Bristol ROADS made a concerted effort to increase the number of people receiving hepatitis C tests by better coordinating services and finding ways to address the complications that prevented people who had agreed to be tested for hepatitis C from actually receiving the test.
    UK, South West Case study PDF
  • Pathways Coordinator Q&A
    Andy Pearson, The Hepatitis C Trust’s Pathways Coordinator, explains the role and the importance of testing and referral pathways for hepatitis C in substance misuse services.
    UK Other, Training PDF
  • Good practice case study: Community pharmacy testing on the Isle of Wight
    This HCV Action good practice case study looks at a community pharmacy testing pilot on the Isle of Wight. It involved the delivery of blood borne virus testing at 22 community pharmacies from September 2014 - May 2015. Primarily focused on increasing the numbers of people tested and diagnosed for hepatitis C, it trebled the number of tests carried out in community open access settings, and led to a significant increase in the numbers of people being referred to specialist care.

    This case study looks at why the pilot was established, how it operated, and the outcomes that it achieved.
    UK, South West Oct 2016 Case study PDF
  • Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
    This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.
    UK, Wales Sep 2016 Strategy & Planning PDF
  • Hepatitis C Coalition: Report on Operational Delivery Network Visits
    This report, published by the Hepatitis C Coalition, provides an overview of visits undertaken by the Coalition to Operational Delivery Networks (ODNs) across England. It sets out the detailed analysis of findings from meetings with a variety of health professionals across the country, and includes a number of recommendations intended to further improve the effectivesness of the ODNs.
    England Sep 2016 Reports & Research PDF

Pages